aTyr Pharma (ATYR)
(Delayed Data from NSDQ)
$5.22 USD
+0.20 (3.98%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $5.22 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, aTyr Pharma, Inc. has a market cap of $446.80M, which represents its share price of $5.02 multiplied by its outstanding shares number of 89.00M. As a small-cap company, ATYR's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ATYR 5.22 +0.20(3.98%)
Will ATYR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ATYR based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ATYR
Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year?
EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Lags Revenue Estimates
ATYR: What are Zacks experts saying now?
Zacks Private Portfolio Services
C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Tops Revenue Estimates
Other News for ATYR
aTyr Pharma management to meet with Cantor Fitzgerald
aTyr Pharma management to meet with Cantor Fitzgerald
Bearish Options Activity Observed in aTyr Pharma (ATYR)
aTyr Pharma Inc put volume heavy and directionally bearish
aTyr Pharma management to meet with Cantor Fitzgerald